Affimed
AFMD
#10485
Rank
NZ$4.97 M
Marketcap
NZ$0.30
Share price
0.00%
Change (1 day)
-82.88%
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Affimed 's latest financial reports the company's current earnings are NZ$0.96 Million. In 2023 the company made an earning of -NZ$0.2 Billion a decrease over its 2022 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion-35.7%
2023 -NZ$0.2 Billion26.6%
2022 -NZ$0.16 Billion36.51%
2021 -NZ$0.12 Billion38.05%
2020 -NZ$80.61 Million33.51%
2019 -NZ$60.38 Million54.17%
2018 -NZ$39.17 Million-32.35%
2017 -NZ$57.9 Million-3.51%
2016 -NZ$60 Million60.24%
2015 -NZ$37.44 Million3296.68%
2014 -NZ$1.11 Million-98.1%
2013 -NZ$58.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
NZ$43.73 M-134.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.78 Million-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.57 M-127.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.46 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA